title: Systemic thrombolytic therapy in acute ischemic stroke--new experiences in spreading network of stroke units in Croatia.
abstract: BACKGROUND
  The aims of this paper are: 1) to present the data of systemic thrombolysis for ischemic stroke in five Croatian centers from July 2008 till January 2010; 2) to compare the results between centers and; 3) to compare data with previously published results from 2006 to 2008 period from our center, and with the data from SITS (Safe Implementation of Treatments in Stroke).
  
  
  METHODS
  We retrospectively reviewed the medical data of thrombolysed patients in following hospitals: University Hospital Center Zagreb (91 patients), University Hospital Split (25 patients), University Hospital Osijek (22 patients), General Hospital Varaždin (21 patient), and General Hospital Zadar (7 patients).
  
  
  RESULTS
  The "time to door" for all centers was 79.71±38.63 min, the "door to needle" period was 64.39±24.18 min. Systolic and diastolic blood pressures at admission were 158.65±27.72 and 90.18±15.03 mm Hg, respectively. Systolic and diastolic blood pressures measured immediately prior to administering rt-PA were 152.19±23.17 and 85.40±15.27 mm Hg, respectively. Initial median NIHSS score was 12, median NIHSS 2h post thrombolysis was 8, and 7th day after rt-PA treatment 4. Intracerebral hemorrhages or secondary hemorrhagic transformations occurred in 21 (12.65%) patients, among which nine were symptomatic. In a 4.5h time window total of 17 patients were thrombolysed. We did not find any differences in outcome between this group and group of patients thrombolysed in the 3h time-window. The group of patients older than 80 years had a worse outcome.
  
  
  CONCLUSIONS
  According to our data, treatment with rt-PA is safe, feasible and effective for stroke patients in both university as well as regional hospitals having stroke units established. Organization of stroke units in regional hospitals, as well as systematic education of public health workers and neurologists, leads to the possibility for each patient to reach the nearest stroke unit and gets the thrombolytic therapy in the therapeutic time window.
authors: University Hospital Center Zagreb, Department of Neurology, Zagreb, Croatia.
authors: Vesna
authors: V
authors: Matijević
authors: Zdravka
authors: Z
authors: Poljaković
authors: Branko
authors: B
authors: Malojčić
authors: Antonija
authors: A
authors: Mišmaš
authors: Antonela
authors: A
authors: Bazina
authors: Marina
authors: M
authors: Boban
authors: Ivica
authors: I
authors: Bilić
authors: Branko
authors: B
authors: Radanović
authors: Klaudia Duka
authors: KD
authors: Glavor
authors: Spomenka
authors: S
authors: Kiđemet-Piskač
authors: Mario
authors: M
authors: Habek
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure / Q000502:physiology; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology*; D002543:Cerebral Hemorrhage / Q000150:complications / Q000453:epidemiology; D017523:Croatia / Q000453:epidemiology; D003627:Data Interpretation, Statistical; D004632:Emergency Medical Services / Q000706:statistics & numerical data; D005260:Female; D006757:Hospital Units / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D010959:Tissue Plasminogen Activator